DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ rallied 1.53% to $55.89 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,976.44 and the Dow Jones Industrial Average rising 1.05% to 49,407.66.

This was the stock's second consecutive day of gains.

Bristol Myers Squibb Co. closed 11.75% short of its 52-week high of $63.33, which the company achieved on March 11th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.54% to $230.75, Pfizer Inc. $(PFE)$ rose 0.83% to $26.66, and Abbott Laboratories $(ABT)$ rose 0.10% to $109.41.

Trading volume (9.4 M) remained 5.2 million below its 50-day average volume of 14.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 2, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

February 02, 2026 16:40 ET (21:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.